Choreo LLC’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Sell
10,992
-3,064
-22% -$848K 0.03% 356
2026
Q1
$4.15M Buy
14,056
+2,240
+19% +$665K 0.05% 247
2025
Q4
$3.26M Buy
11,816
+274
+2% +$74.5K 0.04% 264
2025
Q3
$3.12M Buy
11,542
+387
+3% +$105K 0.04% 279
2025
Q2
$3.07M Buy
11,155
+131
+1% +$35.6K 0.04% 271
2025
Q1
$2.92M Buy
11,024
+4,387
+66% +$1.08M 0.05% 262
2024
Q4
$1.57M Sell
6,637
-3,458
-34% -$795K 0.02% 428
2024
Q3
$2.27M Buy
10,095
+3,992
+65% +$826K 0.03% 323
2024
Q2
$1.19M Buy
+6,103
New +$1.26M 0.02% 465

Other funds holding CME

Choreo LLC's CME Position: Q2 2026 in Review

Choreo LLC reduced its CME Group (CME) stake by 22% in Q2 2026, selling an estimated $848K and leaving 10,992 shares worth $2.43M. The position accounts for 0.03% of the portfolio, ranked #356.

Choreo LLC first reported a position in CME in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.15M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Choreo LLC held 10,992 shares of CME Group worth $2.43M as of Q2 2026.
  • Choreo LLC sold 3,064 CME Group shares in Q2 2026, an estimated $848K.
  • CME Group made up 0.03% of Choreo LLC's portfolio in Q2 2026, its #356 holding.
  • Choreo LLC first reported a position in CME Group in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's CME Group position peaked at $4.15M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.